Celecoxib reduces symptoms in men with difficult chronic pelvic pain syndrome (Category IIIA)

• Published in: Brazilian journal of medical and biological research Vol. 42; no. 10; pp. 963 - 967
• Main Authors: Zhao, W.P., Zhang, Z.G., Li, X.D., Yu, D., Rui, X.F., Li, G.H., Ding, G.Q.
• Format: Journal Article
• Language: English
• Published: Brazil Associação Brasileira de Divulgação Científica 01.10.2009
• Subjects: Adolescent; Adult; BIOLOGY; Celecoxib; Chronic Disease; Chronic pelvic pain syndrome; Cyclooxygenase 2 Inhibitors - therapeutic use; Cyclooxygenase inhibitors; Humans; Male; MEDICINE, RESEARCH & EXPERIMENTAL; Middle Aged; Pain Measurement; Pelvic Pain - drug therapy; Pilot Projects; Prostatitis; Pyrazoles - therapeutic use; Severity of Illness Index; Sulfonamides - therapeutic use; Syndrome; Treatment Outcome; Young Adult; Chronic pelvic pain syndrome; Cyclooxygenase inhibitors; Prostatitis

We investigated the effectiveness of celecoxib in reducing symptoms in patients with difficult chronic pelvic pain syndrome (CPPS), NIH category IIIA. Sixty-four patients with category IIIA CPPS were randomized into two groups of 32 subjects each. One group was treated with celecoxib (200 mg daily)...